

1,402,099 filings since 2004 · latest accepted Nov 4, 2026, 9:28 AM ET
Priority items usually mark a change in credit, accounting integrity, control or listing status: 1.02 Agreement terminated, 1.03 Bankruptcy, 1.05 Cybersecurity incident, 2.04 Debt acceleration, 2.05 Restructuring costs, 2.06 Impairment, 3.01 Delisting notice, 4.01 Auditor change, 4.02 Non-reliance (restatement), 5.01 Change in control.
| Filed | Company | Items | Filing |
|---|---|---|---|
Mar 20, 2026 accepted 5:00 PM ET | ERNAErnexa Therapeutics Inc. | 3.01Delisting notice | DocumentSEC ↗ |
Jul 7, 2025 accepted 4:39 PM ET | ERNAErnexa Therapeutics Inc. | 4.01Auditor change | Document |
Source: SEC EDGAR. Same-day filings appear within minutes and are re-checked against SEC's nightly index. Tickers are current listings, so a company's older filings show its ticker today.
Jan 10, 2025 accepted 4:15 PM ET | ERNAErnexa Therapeutics Inc. | 3.01Delisting notice5.02Officer / director change | DocumentSEC ↗ |
Jan 3, 2025 accepted 4:15 PM ET | ERNAErnexa Therapeutics Inc. | 3.01Delisting notice | DocumentSEC ↗ |
Sep 27, 2024 accepted 4:15 PM ET | ERNAErnexa Therapeutics Inc. | 1.01Material agreement1.02Agreement terminated | DocumentSEC ↗ |
Sep 23, 2024 accepted 4:30 PM ET | ERNAErnexa Therapeutics Inc. | 3.01Delisting notice | DocumentSEC ↗ |
Mar 22, 2024 accepted 4:30 PM ET | ERNAErnexa Therapeutics Inc. | 3.01Delisting notice | DocumentSEC ↗ |
Jan 19, 2024 accepted 4:16 PM ET | ERNAErnexa Therapeutics Inc. | 3.01Delisting notice | DocumentSEC ↗ |
Oct 5, 2023 accepted 4:30 PM ET | ERNAErnexa Therapeutics Inc. | 3.01Delisting notice5.02Officer / director change8.01Other events | DocumentSEC ↗ |
Aug 10, 2023 accepted 4:10 PM ET | ERNAErnexa Therapeutics Inc. | 3.01Delisting notice5.02Officer / director change | DocumentSEC ↗ |
Feb 22, 2023 accepted 5:29 PM ET | ERNAErnexa Therapeutics Inc. | 1.01Material agreement1.02Agreement terminated | DocumentSEC ↗ |
Jan 10, 2023 accepted 4:30 PM ET | ERNAErnexa Therapeutics Inc. | 3.01Delisting notice | DocumentSEC ↗ |
Jan 4, 2023 accepted 8:35 AM ET | ERNAErnexa Therapeutics Inc. | 3.01Delisting notice5.02Officer / director change | DocumentSEC ↗ |
Dec 6, 2022 accepted 4:30 PM ET | ERNAErnexa Therapeutics Inc. | 1.02Agreement terminated | DocumentSEC ↗ |
Nov 23, 2022 accepted 6:15 AM ET | ERNAErnexa Therapeutics Inc. | 3.01Delisting notice | DocumentSEC ↗ |
Nov 22, 2022 accepted 4:06 PM ET | ERNAErnexa Therapeutics Inc. | 1.01Material agreement1.02Agreement terminated7.01Reg FD disclosure | DocumentSEC ↗ |
Jul 1, 2022 accepted 4:30 PM ET | ERNAErnexa Therapeutics Inc. | 3.01Delisting notice | DocumentSEC ↗ |
Jun 17, 2022 accepted 5:21 PM ET | ERNAErnexa Therapeutics Inc. | 3.01Delisting notice4.02Non-reliance (restatement)7.01Reg FD disclosure | DocumentSEC ↗ |
May 27, 2022 accepted 4:35 PM ET | ERNAErnexa Therapeutics Inc. | 3.01Delisting notice7.01Reg FD disclosure | DocumentSEC ↗ |
Apr 19, 2022 accepted 4:30 PM ET | ERNAErnexa Therapeutics Inc. | 4.01Auditor change | DocumentSEC ↗ |
Jan 24, 2022 accepted 5:00 PM ET | ERNAErnexa Therapeutics Inc. | 4.01Auditor change | DocumentSEC ↗ |
Jan 5, 2022 accepted 6:06 AM ET | ERNAErnexa Therapeutics Inc. | 2.05Restructuring costs | DocumentSEC ↗ |
Oct 14, 2021 accepted 4:26 PM ET | ERNAErnexa Therapeutics Inc. | 3.01Delisting notice7.01Reg FD disclosure | DocumentSEC ↗ |
Sep 23, 2021 accepted 4:30 PM ET | ERNAErnexa Therapeutics Inc. | 4.01Auditor change5.02Officer / director change5.03Bylaws / fiscal year7.01Reg FD disclosure | DocumentSEC ↗ |
Apr 23, 2021 accepted 5:20 PM ET | ERNAErnexa Therapeutics Inc. | 4.01Auditor change | DocumentSEC ↗ |
Mar 31, 2021 accepted 5:18 PM ET | ERNAErnexa Therapeutics Inc. | 2.01Acquisition / disposition3.03Holder rights modified5.01Change in control5.02Officer / director change5.03Bylaws / fiscal year8.01Other events | DocumentSEC ↗ |
Jan 15, 2021 accepted 5:22 PM ET | ERNAErnexa Therapeutics Inc. | 1.01Material agreement3.01Delisting notice | DocumentSEC ↗ |
Nov 5, 2020 accepted 8:00 AM ET | ERNAErnexa Therapeutics Inc. | 4.01Auditor change | DocumentSEC ↗ |
Aug 12, 2020 accepted 4:55 PM ET | ERNAErnexa Therapeutics Inc. | 3.01Delisting notice | DocumentSEC ↗ |
Jul 1, 2020 accepted 8:00 AM ET | ERNAErnexa Therapeutics Inc. | 1.02Agreement terminated | DocumentSEC ↗ |
Jun 15, 2020 accepted 4:30 PM ET | ERNAErnexa Therapeutics Inc. | 3.01Delisting notice | DocumentSEC ↗ |
Mar 30, 2020 accepted 4:15 PM ET | ERNAErnexa Therapeutics Inc. | 3.01Delisting notice5.02Officer / director change8.01Other events | DocumentSEC ↗ |
Oct 1, 2018 accepted 8:30 AM ET | ERNAErnexa Therapeutics Inc. | 1.01Material agreement1.02Agreement terminated2.03New debt obligation | DocumentSEC ↗ |
Apr 30, 2018 accepted 8:35 AM ET | ERNAErnexa Therapeutics Inc. | 3.01Delisting notice | DocumentSEC ↗ |
Mar 23, 2018 accepted 5:05 PM ET | ERNAErnexa Therapeutics Inc. | 3.01Delisting notice8.01Other events | DocumentSEC ↗ |
Nov 30, 2017 accepted 8:30 AM ET | ERNAErnexa Therapeutics Inc. | 1.01Material agreement1.02Agreement terminated2.03New debt obligation | DocumentSEC ↗ |
Apr 13, 2016 accepted 4:30 PM ET | ERNAErnexa Therapeutics Inc. | 3.01Delisting notice | DocumentSEC ↗ |
Feb 2, 2016 accepted 7:15 AM ET | ERNAErnexa Therapeutics Inc. | 3.01Delisting notice5.02Officer / director change8.01Other events | DocumentSEC ↗ |
Nov 17, 2015 accepted 7:05 PM ET | ERNAErnexa Therapeutics Inc. | 3.01Delisting notice8.01Other events | DocumentSEC ↗ |
Dec 9, 2013 accepted 3:11 PM ET | ERNAErnexa Therapeutics Inc. | 4.01Auditor change | DocumentSEC ↗ |
May 15, 2008 accepted 5:15 PM ET | ERNAErnexa Therapeutics Inc. | 1.02Agreement terminated5.02Officer / director change | DocumentSEC ↗ |
Oct 10, 2007 accepted 5:20 PM ET | ERNAErnexa Therapeutics Inc. | 4.01Auditor change | DocumentSEC ↗ |
Oct 16, 2006 accepted 5:21 PM ET | ERNAErnexa Therapeutics Inc. | 3.01Delisting notice | DocumentSEC ↗ |
Aug 23, 2004 accepted 5:14 PM ET | ERNAErnexa Therapeutics Inc. | 4.01Auditor change | DocumentSEC ↗ |